Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancer

Original Article

R.J. Kelly, J.A. Ajani, J. Kuzdzal, T. Zander, E.V. Cutsem, G. Piessen, G. Mendez, J. Feliciano, S. Motoyama, A. Lièvre, H. Uronis, E. Elimova, C. Grootscholten, K. Geboes, S. Zafar, S. Snow, A.H. Ko, K. Feeney, M. Schenker, P. Kocon, J. Zhang, L. Zhu, M. Lei, P. Singh, K. Kondo, J.M. Cleary, and M. Moehler

N Engl J Med 2021;384:1191-1203

Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit
  • 1.00 Participation
Course opens: 
03/31/2021
Course expires: 
04/01/2023

Available Credit

  • 1.00 AMA PRA Category 1 Credit
  • 1.00 Participation

Course closed

This course closed on Saturday, April 1, 2023 - 11:59pm.